Member Info for researcher1

I think it is because it proves P. is 'best in class', and if it is there, the chances are.....

bravo! agreed that P. will have served many lives - household name? hmm, only if the household includes a scientist I fear....

hope you managed it in time. Where is everyone? Oh, of course, just another bit of absolutely astonishing good news for the company - nothing new there then.....

of course there are different price targets for different stages: £1 - £2 range is for the submission and approval period; £4 is what AN is aiming for to unlock his bonuses in a couple of years. If I mentioned £12 - £14 then that is the ultimate speculative value of the liquid biopsy market for Angle, but obviously a long range target. Meanwhile all your nervous heebie-jeebies have simply been a waste of everyone's time, including your own.

by my calculation more than half of those new trials will have needed to acquire a new P. unit, so that's already £600K + revenue before FDA and general roll-out!

couldn't agree more - especially that P. roll-out needs to be accelerated for the benefit of all. A much higher SP won't hurt that ambition, so let's hope all those analysts go back to their various burrows and spread the word rapidly. The company is flush with cash, which is great, and take up of the P. units this year will be of an entirely different order - with around 45K pure profit on each.

sold a third of mine at 17.10 earlier, as that's where I feel the MMs had priced it on the sale process announcement.
hope it continues to soar though...

sorry to make you feel lonely gawd. Not much more to say though, is there? Tomorrow AN will go through all the incredible trial results, explain how the Q process works and why the FDA submission is de-risked etc etc, yawn yawn (not!)
It has been an amazing half year for AGL. None of us can say when the sudden uplift in the SP will occur in preparation for approval and immediate worldwide sales, but it will. I have a windfall coming my way Friday - dare I hope the MMs will try a price droop tomorrow pm?

'over the moon' ha ha, yes.
probably more like 'away with the fairies'!

p.s. ...because I was responding specifically to the £1.50 potential valuation

of course market sentiment is a fickle thing, and my 18-32p valuation range could go straight out of the window, and either fly, or drop like a stone...

my calculation was based on dilutions & options over the past 5 years, from a start point of £1.50 = 33p approx. You are correct that Nano was outperforming that on sentiment in 2019, when things were looking a bit rosier...

the SP jumped to 17-18 when the sale process was announced, which I take to be just under the level the MMs had pegged Nano's current value at. With 4x share dilution, Nano's highest valuation ever is the equivalent of 33p now. IF there is more that one party interested, then I expect the bidding to be in that range, i.e. 18 - 32. I sold out of Nano (at 42p) many moons ago when I realised what ME was up to, but couldn't resist buying back in at under the price he recently bought shares! (he's not the sort of bloke to shoot himself in the foot). (though he'll happily blow other people's legs off, metaphorically speaking).

looks horribly leaky, as you'd expect with a two-bit company

please check how many shares have been issued before you throw your pie in the sky FF. Current equivalent of £1.50 five years ago is 33p.

stay calm - they can't hold it back forever - and we are after £1 + not a few pennies - so get buying!

thanks for that - although it is just a summary of all Angle have achieved this year, it is a useful one. Not quite sure how the SP hasn't gone past 80 yet - there must be some twitchy fingers out there!

quite a lot of shares changing hands today - a bit of profit taking (fools!), before a small further toward the Interims. We may have to see how many units have already been sold to gauge the 2020 trajectory, though with the FDA essentially de-risked, I can't see any downside - everyone knows we are looking at up to £2 post-approval, so who would really want to sell this year?

there were a variety of options handed out, SP performance related, with the main tranche being triggered above £4.

hopefully once the US opens we will find a level above 80 today

p.s. remember that Angle shares have already been offered to US investors (at 60p), so Nasdaq may not be a priority just yet